Assort Health, the most advanced specialty-specific AI platform for managing patient phone calls, announced a new round of institutional financing co-led by First Round Capital and Chemistry, with participation from existing investor Quiet Capital.

Assort Health是管理患者电话的最先进的专科专用人工智能平台，宣布了一轮新的机构融资，由First Round Capital和Chemistry共同领投，现有投资者Quiet Capital也参与其中。

This brings Assort Health's total capital raised to $26 million. These investors join Assort Health's existing backers, Four Acres, Tau Ventures, and a number of notable angel investors, including senior executives and founders from Athena Health, Astrana Health, Flatiron Health, Infinitus, Mammoth Biosciences, Mercury, PathAI, and Presto.

这使得Assort Health的总融资额达到2600万美元。这些投资者加入了Assort Health现有的支持者行列，包括Four Acres、Tau Ventures以及多位知名天使投资人，其中不乏来自Athena Health、Astrana Health、Flatiron Health、Infinitus、Mammoth Biosciences、Mercury、PathAI和Presto的高级管理人员和创始人。

The new capital will accelerate the company's mission to improve access to care by eliminating the lengthy hold times and scheduling inefficiencies that plague healthcare organizations..

新资金将加速公司通过消除困扰医疗组织的漫长等待时间和调度效率低下的问题，来改善获取医疗服务的使命。